Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Veneziani I, Alicata C, Pelosi A, et al. Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16− subset. J Immunother Cancer 2022;10:e003385. doi:10.1136/jitc-2021-003385
This article has been corrected since it was first published. An error with figure 2 and the supplemental material has been amended.